Skip to content

Prospective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery

Prospective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14478115
Enrollment
Unknown
Registered
2004-09-21
Start date
2004-01-01
Completion date
Unknown
Last updated
2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain following intermediate thoracic surgery Surgery Post-operative pain

Interventions

Oxycodone modified release 10 mg bd or placebo for 48 hrs postoperatively.

Sponsors

Harefield Hospital (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients scheduled for unilateral intermediate thoracic surgery (e.g. pleural abrasion, talc pleurodesis and lung biopsy)

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026